Sensex Today | Stock Market Live Updates: Nifty falls by close to 300 points; Realty stocks under pressure
Stock Market Live Updates: Indian equity markets are set to react to escalating tensions between India and Pakistan. Late Thursday evening, Indian air defence units successfully intercepted at least eight missiles launched by Pakistan, that targeted key border areas. The Nifty fell nearly 200 points from the day’s high on Thursday,
Read MoreInterested In The New 'Super-Funding' 401k Opportunity? Here's How To Know If You Qualify
-
401(k) funding changes for 2025 now allow investors of a certain age to contribute $11,250 in catch-up funds
-
This super-funding opportunity is available to investors ages 60-63
-
The changes are good news for Gen X’ers in particular,
Watch These Bitcoin Price Levels as Cryptocurrency Reclaims $100,000 Level
Key Takeaways
- Bitcoin surged above the closely watched $100,000 level on Thursday for the first time since early February.
- Thursday’s strong breakout above a consolidation period sets the stage for a potential retest of the cryptocurrency’s record high of $109,000 set in late January.
- Investors should watch crucial overhead areas on bitcoin’s chart around $107,000 and $120,000,
» Read more about: Watch These Bitcoin Price Levels as Cryptocurrency Reclaims $100,000 Level »
Read MoreULIPs, mutual funds or stocks: What's the best for long-term wealth creation?
When it comes to building wealth over the long term, people often come across three popular investment options: ULIPs (Unit Linked Insurance Plans), mutual funds, and stocks. But which one is truly the best for creating wealth over time? Let’s break it down in simple terms.
UNDERSTANDING ULIPs: A MIX OF INSURANCE AND INVESTMENT
ULIPs are a mix of insurance and investment,
» Read more about: ULIPs, mutual funds or stocks: What's the best for long-term wealth creation? »
Read MoreUnpacking the Latest Options Trading Trends in BP
Benzinga’s options scanner has just identified more than 13 option transactions on BP BP -2.08% Get Free Report , with a cumulative value of $734,889. Concurrently, our algorithms picked up 3 puts, …
» Read more about: Unpacking the Latest Options Trading Trends in BP »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
66% Upside In Asian Ride-sharing Stock?
Grab Holdings has evolved into Southeast Asia’s leading super-app with operations spanning ride-hailing, food/grocery delivery, and financial services.
Growth momentum has been strong, particularly since 2023 which was a pivotal year when Grab hit its first quarterly profit. That took place in Q4 2023 on $653 million revenue, up 30% year-on-year.
Under the hood,
» Read more about: 66% Upside In Asian Ride-sharing Stock? »
Read MoreThe Spotlight
10 Billion Reasons To Own This Recession-Proof Stock
With concerns of an impending recession looming large and Goldman Sachs pivoting away from momentum stocks to value stocks, one stock that may fit the bill is Procter & Gamble.
Although the share price has been somewhat volatile subsequent to fiscal Q4 2024 earnings results, P&G bounced back nicely to make an assault on all-time highs.
» Read more about: 10 Billion Reasons To Own This Recession-Proof Stock »